‘Covid-19 cliff edge’: Lateral flow test maker suffers major blow to revenue

Clinical diagnostics specialist Novacyt has suffered a major blow to its revenue, as the feared ‘Covid-19 cliff edge’ comes into focus “faster than expected”. The London-listed company, which provides lateral flow tests, has seen its revenue crumble more than 70 per cent to £16.5m in the first half of this year, compared to £52.2m a year [...]